Good laboratory practice in the pre-analytical phases of testing is becoming increasingly important regardless of the challenges it presents, and the success of each test depends greatly on this being ...

A new chapter is unfolding for gene therapies in Europe. With retinal programs advancing into Phase I/II trials and ...

Antibody-drug conjugates (ADCs) continue to reshape the oncology landscape by combining the target specificity of monoclonal antibodies (mAbs) with the potent cytotoxicity of small-molecule drugs.

The translation of biomarker discoveries into diagnostic applications relies on the robustness of clinical proteomics. Achieving high-throughput, reproducible results requires careful attention to ...

Preliminary results of sequential transarterial chemoembolization and stereotactic body radiotherapy followed by immunotherapy using single tremelimumab regular interval durvalumab in locally advanced ...